Scholarlink

Purpose <p>To evaluate the live birth rate (LBR) following donor frozen embryo transfer (dFET) of preimplantation genetic testing for aneuploidy (PGT-A) versus untested donor embryos, stratified by blastocyst morphologic grade (MG).</p> Methods <p>This was a retrospective cohort study of 146 patients undergoing dFET of a single euploid blastocyst from fresh or frozen oocytes using PGT-A compared to age-matched controls (1:1 ratio) who did not use PGT-A. Primary outcome was LBR. LBR was compared among cohorts, with further stratification by (<b>1) high/low MG</b> and (<b>2) fresh/frozen oocyte status</b>. Secondary outcomes included perinatal outcomes.</p> Result(s) <p>Median age in both groups was 44.5&#xa0;years (<i>p</i> = 0.98). LBR was similar among the two cohorts (PGT-A: 57.5% vs. untested: 50.0%, <i>p</i> = 0.20). There was similar LBR in <b>fresh</b> (PGT-A: 59.2% vs. untested: 50.0%, <i>p</i> = 0.20) and <b>frozen</b> (PGT-A: 47.6% vs. untested: 50.0%, <i>p</i> = 0.85) oocyte subgroups. When stratified by <b>MG</b>, we appreciated similar LBR among <b>high-quality</b> blastocysts (PGT-A-high: 56.5% vs. untested-high: 52.3%, <i>p</i> = 0.49) <b>among the whole cohort</b>, as well as in <b>fresh</b> (fresh-PGT-A-high: 58.3% vs. fresh-untested-high: 52.9%, <i>p</i> = 0.46) and <b>frozen</b> (frozen-PGT-A-high: 44.4% vs. frozen-untested-high: 51.7%, <i>p</i> = 0.59) subgroups. Similarly, we appreciated no difference in LBR among <b>low-quality</b> blastocysts (PGT-A-low: 75.0% vs. untested-low: 31.2%, <i>p</i> = 0.08) <b>among the whole cohort</b>, as well as in the <b>fresh</b> (fresh-PGT-A-low: 80.0% vs. fresh-untested-low: 16.1%, <i>p</i> = 0.08) or <b>frozen</b> (frozen-PGT-A-low: 66.7% vs. frozen-untested-low: 40.0%, <i>p</i> = 0.56) subgroups. Gestational age (37.8&#xa0;weeks, <i>p</i> = 1.0) and infant birth weight (PGT-A: 3128.0&#xa0;g vs. untested: 3150.2&#xa0;g, <i>p</i> = 0.60) were similar.</p> Conclusion(s) <p>Though limited by the small number of MG blastocysts, overall PGT-A did not improve LBR regardless of blastocyst quality from fresh and previously frozen donor oocytes.</p> Capsule <p>Use of PGT-A did not improve live birth rate regardless of blastocyst quality from both fresh and previously frozen donor oocytes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Assessing the impact of both preimplantation genetic testing for aneuploidy with blastocyst morphologic grade on live birth rates in frozen embryo transfers from fresh and frozen donor oocytes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月13日

查看全文
  • Alyson Dennis,
  • Nirali Jain,
  • Emily Auran Clarke,
  • Jennifer K. Blakemore

摘要

Purpose

To evaluate the live birth rate (LBR) following donor frozen embryo transfer (dFET) of preimplantation genetic testing for aneuploidy (PGT-A) versus untested donor embryos, stratified by blastocyst morphologic grade (MG).

Methods

This was a retrospective cohort study of 146 patients undergoing dFET of a single euploid blastocyst from fresh or frozen oocytes using PGT-A compared to age-matched controls (1:1 ratio) who did not use PGT-A. Primary outcome was LBR. LBR was compared among cohorts, with further stratification by (1) high/low MG and (2) fresh/frozen oocyte status. Secondary outcomes included perinatal outcomes.

Result(s)

Median age in both groups was 44.5 years (p = 0.98). LBR was similar among the two cohorts (PGT-A: 57.5% vs. untested: 50.0%, p = 0.20). There was similar LBR in fresh (PGT-A: 59.2% vs. untested: 50.0%, p = 0.20) and frozen (PGT-A: 47.6% vs. untested: 50.0%, p = 0.85) oocyte subgroups. When stratified by MG, we appreciated similar LBR among high-quality blastocysts (PGT-A-high: 56.5% vs. untested-high: 52.3%, p = 0.49) among the whole cohort, as well as in fresh (fresh-PGT-A-high: 58.3% vs. fresh-untested-high: 52.9%, p = 0.46) and frozen (frozen-PGT-A-high: 44.4% vs. frozen-untested-high: 51.7%, p = 0.59) subgroups. Similarly, we appreciated no difference in LBR among low-quality blastocysts (PGT-A-low: 75.0% vs. untested-low: 31.2%, p = 0.08) among the whole cohort, as well as in the fresh (fresh-PGT-A-low: 80.0% vs. fresh-untested-low: 16.1%, p = 0.08) or frozen (frozen-PGT-A-low: 66.7% vs. frozen-untested-low: 40.0%, p = 0.56) subgroups. Gestational age (37.8 weeks, p = 1.0) and infant birth weight (PGT-A: 3128.0 g vs. untested: 3150.2 g, p = 0.60) were similar.

Conclusion(s)

Though limited by the small number of MG blastocysts, overall PGT-A did not improve LBR regardless of blastocyst quality from fresh and previously frozen donor oocytes.

Capsule

Use of PGT-A did not improve live birth rate regardless of blastocyst quality from both fresh and previously frozen donor oocytes.